United States Últimas notícias

MediWound (NASDAQ:MDWD) reported a decline in revenue for the first quarter of 2026 as the company heavily prioritized research and development funding for its late-stage clinical programs.

Bath & Body Works (NYSE:BBWI) reported a 3% decline in net sales for the first quarter of 2026, reflecting a broader normalization of consumer spending within the beauty and home fragrance categories.

Sound Point Meridian Capital (NYSE:SPMC) announced its financial results for the fourth fiscal quarter ended March 31, 2026, reporting a net asset value per share of $9.63 for its common stock.

Dycom Industries (NYSE:DY) reported record financial results for its fiscal first quarter of 2027, driven by strong demand for digital infrastructure deployments.

Manchester United (NYSE:MANU) reported a sharp turnaround in operating profitability for the first nine months of fiscal 2026, fueled by aggressive restructuring initiatives and a successful domestic campaign.

Dick’s Sporting Goods (NYSE:DKS) reported a 62.7% surge in consolidated net sales for the first quarter of 2026, marking its first full quarter of financial consolidation since acquiring Foot Locker.

Movado Group (NYSE:MOV) reported a sharp increase in operating income and profitability metrics for the first quarter of fiscal 2027, driven by higher net sales and improved operational execution across its core wholesale and direct-to-consumer networks.

European Central Bank Vice President Luis de Guindos discusses the impact of the energy supply shock on inflation and euro-area growth. "If you look at soft indicators, sentiment indicators, these indicators clearly point at an important impact on growth," Guindos says during an interview with Bloomberg's Mark Schroers.

Capri Holdings (NYSE:CPRI) reported a 3.7% decline in fourth-quarter revenue for fiscal 2026, as the luxury fashion group continued to navigate broader demand headwinds across the global consumer discretionary sector.

Apogee Therapeutics (NASDAQ:APGE) has entered into a strategic financing collaboration with Blackstone Life Sciences, securing up to $1.3 billion in flexible, non-dilutive capital.

Apogee Therapeutics (NASDAQ:APGE) reported positive mid-stage clinical data for its experimental eczema treatment, paving the way for late-stage trials later this year alongside a new multi-indication financing deal with Blackstone Life Sciences.

Former US Centcom Commander General Joseph Votel (Ret.), discusses the challenges faced by the US military in the Strait of Hormuz and in finding a peaceful solution to the war in Iran.